Fujirebio Europe receives CE mark for automated Lumipulse G SARS-CoV-2 antigen assay and ESPLINE SARS-CoV-2 rapid antigen device
Fujirebio Europe has received CE marking for their Lumipulse G SARS-CoV-2 Ag, a high-sensitivity antigen test for the fully automated CLEIA (chemiluminescent enzyme immunoassay) Lumipulse G system, and of the ESPLINE SARS-CoV-2 rapid antigen test. Fujirebio is a global leader in the field of high-quality in vitro diagnostics (IVD) testing. The Lumipulse G series are […]
